These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 10565683

  • 1. Biochemical uncovering of mdm2/p53 complexes in liposarcomas parallels their immunohistochemical detection.
    Butò S, Pierotti MA, Tamborini E, Della Torre G, Lavarino C, Rilke F, Pilotti S.
    Diagn Mol Pathol; 1999 Sep; 8(3):125-30. PubMed ID: 10565683
    [Abstract] [Full Text] [Related]

  • 2. Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms.
    Pilotti S, Della Torre G, Lavarino C, Di Palma S, Sozzi G, Minoletti F, Rao S, Pasquini G, Azzarelli A, Rilke F, Pierotti MA.
    J Pathol; 1997 Jan; 181(1):14-24. PubMed ID: 9071998
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Distinction between lipoma and liposarcoma by MDM2 alterations: a case report of simultaneously occurring tumors and review of the literature.
    Boltze C, Schneider-Stock R, Jäger V, Roessner A.
    Pathol Res Pract; 2001 Jan; 197(8):563-8. PubMed ID: 11518050
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of MDM2 and CDK4 amplification by real-time PCR on paraffin wax-embedded material: a potential tool for the diagnosis of atypical lipomatous tumours/well-differentiated liposarcomas.
    Hostein I, Pelmus M, Aurias A, Pedeutour F, Mathoulin-Pélissier S, Coindre JM.
    J Pathol; 2004 Jan; 202(1):95-102. PubMed ID: 14694526
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Analysis of MDM2 and TP53 genes in canine liposarcoma.
    Muscatello LV, de Biase D, Maloberti T, di Oto E, Tallini G, Pellegrino V, Bacci B, Roccabianca P, Lepri E, Crippa L, Avallone G.
    Sci Rep; 2024 Jun 18; 14(1):14087. PubMed ID: 38890407
    [Abstract] [Full Text] [Related]

  • 16. In vitro and in silico studies of MDM2/MDMX isoforms predict Nutlin-3A sensitivity in well/de-differentiated liposarcomas.
    Bozzi F, Conca E, Laurini E, Posocco P, Lo Sardo A, Jocollè G, Sanfilippo R, Gronchi A, Perrone F, Tamborini E, Pelosi G, Pierotti MA, Maestro R, Pricl S, Pilotti S.
    Lab Invest; 2013 Nov 18; 93(11):1232-40. PubMed ID: 24018792
    [Abstract] [Full Text] [Related]

  • 17. Limited role of TP53 and TP53-related genes in myxoid liposarcoma.
    Pilotti S, Lavarino C, Mezzelani A, Della Torre C, Minoletti F, Sozzi G, Azzarelli A, Rilke F, Pierotti MA.
    Tumori; 1998 Nov 18; 84(5):571-7. PubMed ID: 9862519
    [Abstract] [Full Text] [Related]

  • 18. Analysis of the molecular species generated by MDM2 gene amplification in liposarcomas.
    Tamborini E, Della Torre G, Lavarino C, Azzarelli A, Carpinelli P, Pierotti MA, Pilotti S.
    Int J Cancer; 2001 Jun 15; 92(6):790-6. PubMed ID: 11351297
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.